4th Quarter - Report

TIBER CREEK GROUP for ASTELLAS PHARMA US, INC.

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues relating to drug pricing, march-in rights under Bayh-Dole Act P.L. 96-517 and transparency. Issues related to the Medicare Part D coverage gap

Foreign entity interest: Astellas Pharma, Inc. based in Tokyo, Japan and as identified in our Lobbying Registration, has an interest as a pharmaceutical company in all of the issues with respect to which Astellas Pharma US has lobbied and listed above.

LobbyistCovered position, as disclosed
JOHN MICHAEL GONZALEZ —
JONATHON JONES —
SEAN RICHARDSON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Foreign Relations FOR

S. 2482 - Foreign Agents Registration Amendment Act of 2018; S. 2039 - Disclosing Foreign Influence Act; HR 4170 - Disclosing Foreign Influence Act

Foreign entity interest: Astellas Pharma, Inc. based in Tokyo, Japan and as identified in our Lobbying Registration, has an interest as a pharmaceutical company in all of the issues with respect to which Astellas Pharma US has lobbied and listed above.

LobbyistCovered position, as disclosed
JOHN MICHAEL GONZALEZ —
JONATHON JONES —
SEAN RICHARDSON —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 4170 (115th), S. 2482 (115th), S. 2039 (115th)

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.